Varicella Virus Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The Evaluation of Immunogenicity and Safety of NBP608 in Healthy Children 12 Months to 12 Years of Age
Condition: Varicella Interventions: Biological: NBP608; Biological: Varivax Sponsor: SK Chemicals Co.,Ltd. Completed - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2017 Category: Research Source Type: clinical trials

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age
Condition: Varicella Interventions: Biological: NBP608; Biological: Varivax Sponsor: SK Chemicals Co.,Ltd. Active, not recruiting - verified April 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2017 Category: Research Source Type: clinical trials

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Condition: InfluenzaInterventions: Biological: Influenza vaccine GSK2321138A; Biological: Havrix Junior; Biological: Prevenar 13; Biological: Varivax/ProVarivax; Biological: VarilrixSponsor: GlaxoSmithKlineActive, not recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2011 Category: Research Source Type: clinical trials

An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Condition: InfluenzaInterventions: Biological: Influenza vaccine GSK2321138A; Biological: Havrix Junior; Biological: Prevenar 13; Biological: Varivax/ProVarivax; Biological: VarilrixSponsor: GlaxoSmithKlineCompleted - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 21, 2011 Category: Research Source Type: clinical trials